NCT00107159View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

September 30, 2010

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00107159 - Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter